Join us for the 2020 Down Syndrome Research Symposium
Each year we host a full-day of exciting research updates from the University of Colorado and more
We are hiring postdoctoral fellows and data scientists
COVID-19 has not slowed our critical research mission. Join our team
Research opportunity for people with Down syndrome who have an immune skin condition
Our newest research initiative is an NIH-funded clinical trial testing the safety and efficacy of a drug called tofacitinib
Improving the lives of people with Down syndrome through advanced biomedical research
Over 50 teams of researchers are working across the CU campuses on numerous exciting projects
We use state-of-the-art, transformational research platforms to decipher the unique biology and disease spectrum caused by trisomy of chromosome 21.
Our ultimate goal is to enable precision medicine approaches to improve health outcomes in Down syndrome, including the development of new diagnostic and therapeutic tools.
Sie Center and University researchers investigate corneal morphology in young individuals with Down syndrome
Hyper Immune System May Be Key to Down Syndrome Symptoms
Should people with Down syndrome be considered high-risk during COVID-19? Dr. Espinosa reviews the evidence.
CU Anschutz at the forefront of breakthroughs in Down syndrome research on World Down Syndrome Day
We are the largest geographical cluster of Down syndrome researchers in the world
Comprised of over 50 Principal Investigators and countless more contributing scientists from across the University of Colorado campuses, our researchers bring expertise from a variety of fields.
Together, we are working to decipher the complex mechanisms and multi-faceted health impacts of trisomy 21.
